News
Many everyday symptoms are inconsequential. You have a poor night’s sleep to thank for your bloodshot eyes, or a new lotion ...
With summer in full swing, Dr. Elnaz Firoz of the Warren Alpert Medical School and the Miriam Hospital dispels sunscreen ...
CHARLOTTE — Skin cancer is the most common cancer in the United States, but for Black people, cancer signs can show up in unexpected places, and missing them can have serious consequences. Consumer ...
CEO of Cancer Support Community Arizona Julie Dunnigan told KTAR News 92.3 FM skin cancer is more common in Arizona compared to the rest of the country due to sun exposure, the UV index and elevation.
21d
Health on MSNPictures of What Skin Cancer Looks LikeMedically reviewed by Katlein Franca, MD Skin cancer is a type of cancer that begins in the skin cells, and its appearance can vary widely depending on the type of cancer. Understanding the variations ...
In fact, in the United States alone, an estimated 5.4 million cases of skin cancer are diagnosed annually. While moles and rashes are commonly associated with skin cancer, several other indicators ...
ATOMIC Kitten’s Natasha Hamilton opened up about her skin cancer battle, revealing she was diagnosed with the disease after getting a persistent itchy spot on her back. In an interview on Goo… ...
Sometimes, skin cancer—especially basal cell carcinoma—can appear as a flat, shiny area that almost looks like scar tissue. It might feel smooth, slightly firm, or look pale and stretched.
LUT014 gel significantly reduces acne-like rashes from anti-EGFR therapies in colorectal cancer patients, improving quality of life. The phase 2 trial showed 70% improvement with high-dose gel, ...
In each case, the gel was applied once a day for 28 days. The main goal was to see if the rash improved, either by one level of severity or through better quality-of-life scores related to skin ...
Patients had colorectal cancer and developed moderate to severe rashes while taking cetuximab or panitumumab, two common anti-EGFR treatments. The participants were randomly divided into three groups.
A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results